Samsung Biologics News and Resources

CDMO News

Samsung Biologics and LegoChem: A Strategic Partnership for ADC Manufacturing

Samsung Biologics, a global contract development and manufacturing organisation (CDMO), has entered into a strategic partnership with LegoChem Biosciences, a biotech company at the forefront of the research and development of antibody-drug conjugate (ADC) programs. This partnership was announced on February 7,

8 February 2024

Samsung Biologics

Samsung Biologics is a Contract Service, CMO/CDMO, Biopharmaceutical company company operating in the pharmaceutical industry. Samsung Biologics is a fully integrated, end-to-end CDMO service provider, offering seamless development and manufacturing solutions from cell line development to final aseptic fill/finish as

27 November 2023

Welcome to PharmaSource

Join the global community of outsourcing & procurement professionals from the world’s leading pharma and biotechs:

Stay ahead of trends and best practices

Exclusive downloads and podcasts

Get invites to special events and meetups

Sign up for your free membership

Samsung Biologics News and Resources

Samsung Biologics and LegoChem: A Strategic Partnership for ADC Manufacturing

Samsung Biologics

Welcome to PharmaSource

Follow us

Top Links

Get in touch

Who do you rate?

Recommend a Supplier